Prise en charge du sepsis grave et du choc septique : survivre au sepsis

Dellinger, 2004, Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, Crit Care Med, 32, 858, 10.1097/01.CCM.0000117317.18092.E4 Dellinger, 2008, Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, Crit Care Med, 36, 296, 10.1097/01.CCM.0000298158.12101.41 Dellinger, 2013, Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock 2012, Crit Care Med, 41, 580, 10.1097/CCM.0b013e31827e83af Atkins, 2004, Grading quality of evidence and strength of recommendations, Brit Med J, 328, 1490, 10.1136/bmj.328.7454.1490 Kumar, 2006, Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock, Crit Care Med, 34, 1589, 10.1097/01.CCM.0000217961.75225.E9 Guidet, 2012, Assessment of hemodynamic efficacy and safety of 6 % hydroxyethylstarch 130/0.4 vs 0.9 % NaCl fluid replacement in patients with severe sepsis: the CRYSMAS Study, Crit Care, 16, T94, 10.1186/cc11358 Perner, 2012, Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis, N Engl J Med, 367, 124, 10.1056/NEJMoa1204242 Myburgh, 2012, Hydroxyethyl starch or saline for fluid resuscitation in intensive care, N Engl J Med, 367, 1901, 10.1056/NEJMoa1209759